Thurston, Springer, Miller, Herd & Titak, Inc. Charles River Laboratories International, Inc. Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $558 Million
- Q1 2025
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 3 shares of CRL stock, worth $319. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3Holding current value
$319% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
709Shares Held
50MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$657 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$542 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$233 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$193 Million0.56% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$192 Million0.79% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $5.42B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...